Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Journal of Endocrinological Investigation
|
January 30, 2003
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor
R M Ruggeri, D Villari, A Simone, et al.
Transplantation Proceedings
|
September 27, 2005
The treatment of fistulae and ureteral stenosis after kidney transplantation
V Li Marzi, M T Filocamo, E Dattolo, et al.
Journal of Hepatology
|
January 1, 1991
HBe antibody unrelated to 'e minus' hepatitis B virus variant infection in patients with chronic type D hepatitis
G Raimondo, G RodinĂ², S Brancatelli, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 4, 2001
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules
M Trovato, D Villari, R M Ruggeri, et al.
Cytometry
|
September 15, 1996
Flow cytometric measurement of DNA content in human solid tumors: a comparison with cytogenetics
S Rapi, A Caldini, A Fanelli, et al.
European Journal of Endocrinology
|
April 15, 2004
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia
C Crescioli, P Ferruzzi, A Caporali, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|
August 22, 2013
Synchronous bilateral testicular germ cell tumour: case report and review of the literature
B Detti, S Scoccianti, S Cassani, et al.
Oncology Reports
|
May 25, 2011
Cyclophosphamide, epidoxorubicin and Carboplatin as treatment for advanced-carcinoma of the bladder - a phase-ii study
B Neri, G Nicita, N Stomaci, et al.
Anti-Cancer Drugs
|
December 23, 2004
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial
B Neri, G Cipriani, C Fulignati, et al.
Clinical Chemistry and Laboratory Medicine
|
July 4, 2001
Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system
S Gelmini, C Tricarico, G Vona, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Journal of Endocrinological Investigation
|
January 30, 2003
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor
R M Ruggeri, D Villari, A Simone, et al.
Transplantation Proceedings
|
September 27, 2005
The treatment of fistulae and ureteral stenosis after kidney transplantation
V Li Marzi, M T Filocamo, E Dattolo, et al.
Journal of Hepatology
|
January 1, 1991
HBe antibody unrelated to 'e minus' hepatitis B virus variant infection in patients with chronic type D hepatitis
G Raimondo, G RodinĂ², S Brancatelli, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 4, 2001
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules
M Trovato, D Villari, R M Ruggeri, et al.
Cytometry
|
September 15, 1996
Flow cytometric measurement of DNA content in human solid tumors: a comparison with cytogenetics
S Rapi, A Caldini, A Fanelli, et al.
European Journal of Endocrinology
|
April 15, 2004
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia
C Crescioli, P Ferruzzi, A Caporali, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|
August 22, 2013
Synchronous bilateral testicular germ cell tumour: case report and review of the literature
B Detti, S Scoccianti, S Cassani, et al.
Oncology Reports
|
May 25, 2011
Cyclophosphamide, epidoxorubicin and Carboplatin as treatment for advanced-carcinoma of the bladder - a phase-ii study
B Neri, G Nicita, N Stomaci, et al.
Anti-Cancer Drugs
|
December 23, 2004
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial
B Neri, G Cipriani, C Fulignati, et al.
Clinical Chemistry and Laboratory Medicine
|
July 4, 2001
Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system
S Gelmini, C Tricarico, G Vona, et al.
Page
of 7